Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02278874 · ClinicalTrials.gov registry record
High Risk Multiple Gestation Study
A clinical trial, sponsored by Natera.
- Completed
- Registry status
- 99
- Enrollment target
NCT02278874 is a clinical trial that has completed, run by Natera. The registered enrollment target is 99 participants.
The verdict
NCT02278874 has completed, sponsored by Natera.
- COMPLETED
- Registry status
- 99 participants
- Enrollment target
Study Summary
The objectives of the clinical study are to demonstrate the accuracy of our proprietary algorithm method to determine the genetic health of the developing fetuses in a multiple gestation pregnancy from a maternal blood sample. The long term goal of this study will be the development of a method of minimally invasive prenatal diagnosis that has a higher sensitivity and lower false positive rate in the intended population (e.g. multiple gestation pregnancies) than other currently available screening tests. This will result in fewer unnecessary amniocenteses and Chorionic Villus Sample (CVS) procedures, which are associated with a risk of miscarriage.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2014-08 |
| Est. Completion | 2019-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02278874
The ClinicalTrials.gov registry entry for NCT02278874 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 99 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Natera, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02278874 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02278874 about?
NCT02278874 is a clinical study titled "High Risk Multiple Gestation Study". The objectives of the clinical study are to demonstrate the accuracy of our proprietary algorithm method to determine the genetic health of the developing fetuses in a multiple gestation pregnancy from a maternal blood sample. The long term goal of this study will be the development of a method of m...
What is the current status of trial NCT02278874?
This trial is currently completed. The enrollment target is 99 participants. The study started on 2014-08. Estimated completion is 2019-03.
Who is sponsoring clinical trial NCT02278874?
This trial is sponsored by Natera, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.